These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26595692)

  • 61. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
    Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potential adverse effects of proton pump inhibitors.
    Coté GA; Howden CW
    Curr Gastroenterol Rep; 2008 Jun; 10(3):208-14. PubMed ID: 18625128
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acid-suppressive drugs and community-acquired pneumonia.
    Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
    Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease].
    Juhász M; Tulassay Z
    Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PPIs and fracture risk.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
    [No Abstract]   [Full Text] [Related]  

  • 70. [Proton pump inhibitors (PPI): may be not as harmless as believed].
    Reinberg O
    Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Common questions about the management of gastroesophageal reflux disease.
    Anderson WD; Strayer SM; Mull SR
    Am Fam Physician; 2015 May; 91(10):692-7. PubMed ID: 25978198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS
    Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety of proton pump inhibitor exposure.
    Yang YX; Metz DC
    Gastroenterology; 2010 Oct; 139(4):1115-27. PubMed ID: 20727892
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gastroesophageal reflux disease management and chronic use of proton pump inhibitors.
    Howland AM
    JAAPA; 2023 Dec; 36(12):1-6. PubMed ID: 37989196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pre-dinner administration increases the efficacy of proton pump inhibitors on refractory GERD symptoms in connective tissue disease patients.
    Iwata A; Ikeda K; Hirose K; Takatori H; Takahashi K; Sanayama Y; Tanaka S; Suto A; Nakajima H
    Mod Rheumatol; 2013 Mar; 23(2):357-64. PubMed ID: 22614239
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PPI therapy: when to worry about fracture risk.
    Heidelbaugh JJ
    J Fam Pract; 2011 May; 60(5):255-60. PubMed ID: 21544271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.